Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs GNRC✓SelectedUSD · GNRCGSK vs GNRC performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs GNRC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+184.8%
GNRC return
+2,294.2%
Excess return
-2,109.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGNRCExcessAlpha
1D-1.6%-0.2%-1.4%-1.5%
7D-4.7%+6.3%-11.0%-5.3%
30D-4.7%+5.4%-10.1%-5.4%
3M-8.8%-2.7%-6.0%-9.1%
6M-4.6%-15.9%+11.3%-4.2%
YTD+1.0%+50.4%-49.4%-5.0%
1Y+6.9%+39.3%-32.4%+1.2%
3Y+52.5%+79.7%-27.2%+38.0%
5Y+40.3%-52.8%+93.1%+43.6%
10Y+99.0%+396.1%-297.1%+37.8%
All+184.8%+2,294.2%-2,109.4%+41.7%

Cumulative growth

Daily Returns

Daily percentage return beside GNRC.

Daily Out/Under-Performance

Portfolio return minus GNRC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GNRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GNRC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling